AKT1 and glioblastoma: In vivo experiments showed that celastrol increased the levels of cleaved Caspase-3, LC3B, and p-JNK, decreased the expression of p-AKT and mTOR, and inhibited the growth of tumors in a mouse glioblastoma in situ transplantation model.